Marwyn Value Investors Limited

Net Asset Value • Feb 14, 2020

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 0907D

Marwyn Value Investors Limited

14 February 2020

LEI: 213800L5751QTTVEA774

14 February 2020

Marwyn Value Investors Limited

Net Asset Value per Realisation Share

The board of directors of Marwyn Value Investors Limited (the "Company") today announces that the estimated net asset value per realisation share of the Company based on the estimated value of its interests in Marwyn Value Investors L.P. is £1.74783 as at 31 January 2020. As at 31 January 2020 there were 4,187,226 realisation shares in issue.

As at 31 January 2020 the closing mid share price of a realisation share in the Company was £1.4250 and represented a discount of 18.47% to the net asset value per realisation share.

Historic Performance

	Estimated NAV per share (£)	Movement over Period (%)	Movement over Month (%)	Year to date Movement (%)	NAV Inception to date (%) *
2020:
January 31	1.74783	+0.4	+0.4	+0.4	-19.0
January 24	1.74150	-4.0	+0.1	+0.1	-19.3
January 17	1.81431	+1.2	+4.3	+4.3	-15.9
January 10	1.79269	+3.0	+3.0	+3.0	-16.9
2019:
December 31	1.74002		+7.1	-12.9	-19.3
November 29	1.62433		+0.4	-18.7	-24.7
October 31	1.61749		-1.1	-19.0	-25.0
September 30	1.63576		-3.0	-18.1	-24.2
August 30	1.68588		-11.4	-15.6	-21.8
July 31	1.90305		-0.6	-4.7	-11.8
June 30	1.91533		+5.8	-4.1	-11.2
May 31	1.81043		-4.2	-9.4	-16.1
April 30	1.89061		+1.8	-5.3	-12.3
March 29	1.85765		-2.0	-7.0	-13.9
February 28	1.89479		-0.1	-5.1	-12.1
January 31	1.89754		-5.0	-5.0	-12.0

* Inception to date is calculated from the creation of the realisation shares on 30 November 2016.

Enquiries to:

Axio Capital Solutions Limited

One Waverley Place

Union Street

St Helier

Jersey

JE1 1AX

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

NAVLZLFFBLLFBBV